Form 4: Director Brett Brodnax Receives Lumexa RSU Grant

Director Brett Brodnax was granted 19,358 restricted stock units in Lumexa Imaging Holdings, Inc. on June 10, 2026.

Summary

• Director Brett Brodnax acquired 19,358 restricted stock units (RSUs) of Lumexa Imaging Holdings, Inc. (LMRI).
• Each RSU represents a contingent right to receive one share of common stock.
• The grant was issued at a price of $0 per share.
• Following this transaction, the reporting person's total beneficial ownership is 81,385 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting of RSUs is subject to the reporting person's continued service with the issuer.

Future Outlook

The RSUs will vest on the earlier of the one-year anniversary of the grant date (June 10, 2027) or the next annual meeting of stockholders, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term performance and align leadership with shareholder value.

Comparison to Industry Standards

• The issuance of RSUs as part of director compensation is consistent with standard practices for publicly traded companies in the healthcare and imaging technology sectors.

Stakeholder Impact

• Minor dilution impact upon future vesting of RSUs.

Next Steps

• Vesting of the 19,358 RSUs on the earlier of June 10, 2027, or the next annual meeting.

Key Dates

Keywords

Lumexa Imaging Holdings, LMRI, Form 4, Insider Trading, Restricted Stock Units, Director Compensation